London Court of Appeal Validates IPCom's Mobile Telecoms Patent Critical to the UMTS Standard
IPCom GmBH & Co. KG / London Court of Appeal Validates IPCom's Mobile Telecoms Patent Critical to the UMTS Standard . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Mobile Telecoms Patent is essential to UMTS networks
MUNICH, Germany, Jan. 09, 2018 (GLOBE NEWSWIRE) -- IPCom, a leading patent licensing entity with a global portfolio of mobile telecommunications patents, today announced that, earlier in 2017, the London Court of Appeal confirmed both the validity and infringement of IPCom's mobile telecoms European Patent (EP 1 841 268) (the "'100A") in its decision against the leading global handset vendor, HTC. The confirmation by the Court of Appeal of the validity of this critical patent and of HTC's infringement demonstrates the value and quality of this technology to mobile telecommunications companies. In the event that the parties are unable to reach a settlement on the terms of a fair, reasonable and non-discriminatory ("FRAND") license, the parties will move next to the damages inquiry phase of the action. In addition to the 100A action in the United Kingdom, as part of its ongoing effort to protect its intellectual property rights, IPCom recently filed a lawsuit against HTC in Germany for infringement of two additional IPCom patents.
"We're pleased the Court found, after significant investigation and appeals, that the 100A is valid and essential to the UMTS standard," said Bernhard Frohwitter, managing director and co-founder of IPCom. "At long last, this paves the way for the industry as a whole to move forward with clear direction established by the court system. IPCom, with a portfolio of over 1,150 relevant or essential patents, stands ready to engage diligently with all manufacturers and service providers in the mobile industry."
Achieving this confirmation of validity and infringement was long and hard-fought but the decision by the Court of Appeal establishes that the 100A is standard-essential and mandatory to the UMTS standard. This particular patent is related to controlling how UMTS mobile telephones gain initial access to the network. As a result, any entity developing networks, handsets, or equipment for today's mobile networks should be engaging with IPCom regarding this critical element, as well as the hundreds of other relevant mobile technology patents within the firm's portfolio.
IPCom continues to engage with any industry participants who wish to take licenses on FRAND conditions as set forth by the European Commission and relayed to the European Telecommunications Standards Institute (ETSI). IPCom has a policy of offering all market participants implementing standards-compliant products and services FRAND licences and has been diligently doing so for many years. The confirmation of the 100A's validity and infringement by implementation of the UMTS standard reinforces the fact that UMTS implementors, if not already licensed, should be taking steps to negotiate with IPCom concerning its essential patent portfolio.
Companies manufacturing or selling mobile devices or offering services compliant with 2G (GMS), 2.5G (GPRS), 3G (UMTS) and 4G (LTE) should, therefore, contact IPCom to request a FRAND license agreement. To request a license, please send your company name and contact information to email@example.com.
IPCom is a Patent Licensing Entity founded in 2007 to establish a link between patent developers and patent users. Its core business is the global licensing of patents from its own portfolio to manufacturers in the industry. Bosch originally developed IPCom's patents. The current patent portfolio encompasses approximately 1150 patents in the field of mobile communications, registered in Europe, the US and Asia. Among these are a number of patents that are declared standard-essential for the key mobile communications standards of 2G (GMS), 2.5G (GPRS), 3G (UMTS) and 4G (LTE).
For more information:
Tel: +1 408-772-1551
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: IPCom GmBH & Co. KG via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Equis and Global Infrastructure Partners Announce Closing of US$5.0 Billion Renewable Energy Generation Acquisition of Equis Energy19.1.2018 17:28 | Pressemelding
Singapore, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Equis Pte. Ltd (Equis) and Global Infrastructure Partners (GIP) announcedtoday the closing of the previously announced sale by Equis of 100% of the equity interest in Equis Energyto GIP and its co-investors, for an enterprise value of USD5.0 billion (including assumed liabilities of USD1.3bn). The net transaction consideration has been settled in cash. Headquartered in Singapore, Equis Energy is the largest renewable energy independent power producer(IPP) in the Asia-Pacific region (APAC), with more than 180 assets comprising 11,135MW in operation,construction and development across APAC including Australia, Japan, India, Indonesia, the Philippinesand Thailand. The transaction is the largest renewable energy generation acquisition in history and positions GIP as adominant renewable energy developer in the key OECD growth markets of Australia and Japan, as well asacross India and South-East Asia. About Equis Energy Equis Energy operates from
XBiotech Announces Presentation of Phase 2 Open Label Extension Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa19.1.2018 14:00 | Pressemelding
Open Label Extension Results, which Demonstrate Significant Improvements in HS Patients Previously Treated with Placebo, will be Presented at the 7th Conference of the European Hidradenitis Suppurativa Foundation (EHSF) AUSTIN, Texas, Jan. 19, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that results from an open label extension (OLE) phase of the randomized Phase 2 study evaluating XBiotech's True Human(TM) antibody, MABp1, as a treatment for Hidradenitis Suppurativa (HS), will be presented at the European Hidradenitis Suppurativa Foundation (EHSF) Conference occurring in Rotterdam Netherlands February 7-9th. The oral presentation titled, "An open-label extension study of MABp1 targeting interleukin-1alpha for hidradenitis suppurativa (HS)" will be given by Theodora Kanni, M.D., Ph.D., Attikon University Hospital in Athens Greece, on 8 February 2018 between 1:50 and 2:50pm local time. The findings being presented come from patients that had received placebo in
The Search for #AconfidentYou Role Models Kicks Off at the Xehar Fashion Fairies Conference19.1.2018 12:00 | Pressemelding
Expanding their Fashion Fairies Program, Xehar Teaches and Inspires Women Through Confidence EL SEGUNDO, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Today, the Xehar team announces the Xehar Fashion Fairies Conference, which takes place over three days in Los Angeles, January 19th-21st. The conference gathers aspiring fashionistas to celebrate self love, natural beauty, and learn what it takes inspire women to be more confident. With powerful keynotes, exciting breakout sessions, a fashion show and international networking opportunities, the conference is a unique blend that is new to the fashion industry. "We are searching for our 2018 Fashion Fairies who are serious about a career in fashion and want to inspire women worldwide," says Hadari Oshri, founder and CEO of Xehar. "Attendees will learn how to become one of our exclusive #AconfidentYou Fashion Fairies." Propelled by the successful launch of its existing influencer outreach, Xehar has now expanded their Fashion Fairies program t
Olympus Labs Partners with Leading Korean Fintech Company Metaps Plus19.1.2018 00:03 | Pressemelding
Gibraltar, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Olympus Labs is quickly becoming an emerging global leader in the cryptocurrency-based financial product space, and on the heels of a successful token sale, Olympus is partnering with Seoul-based corporation Metaps Plus, a leading Korean fintech company and mobile marketing platform developer. This news comes shortly after the company announced OKEx, as its official exchange for the company's token MOT. "This is an amazing partnership for us, as it will allow us to hit the Korean market in a big way. We will be able to tap directly into the tens of millions of users on the Metaps Plus platform, allowing users to access financial products created by Olympus," said Kai Chen, CEO of Olympus Labs. "This is a key milestone as it demonstrates that Olympus products can be integrated in third party platforms such as mobile apps, wallets, exchanges, and even physical atms and pos systems, allowing users throughout the world access to Olympus products
Forward Industries Acquires Intelligent Product Solutions18.1.2018 23:54 | Pressemelding
WEST PALM BEACH, Fla. and HAUPPAUGE, N.Y., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Forward Industries (NASDAQ:FORD) today announced the acquisition of Intelligent Product Solutions (IPS), an industry leading product design and development company based in Long Island, New York for a material consideration comprising of cash, equity, and contingent earn outs. IPS clients include leading brands in consumer electronics, medical devices, enterprise and security solution providers and Internet of Things connected solutions, including Google, Physio Control, PepsiCo, Motorola, ABInBev, Zebra and Charity Water. Commenting on the transaction, Terry Wise, CEO of Forward Industries remarked, "I am delighted and excited with the acquisition of IPS. The company is an excellent strategic fit for Forward Industries. Its expertise and strong track record in designing connected/IOT products and developing products such as the AdhereTech 'smart' pill bottle will significantly strengthen and contribute to For
VITEC to Highlight EZ TV IPTV and Digital Signage Platform in First ISE Appearance18.1.2018 21:06 | Pressemelding
PARIS, Jan. 18, 2018 (GLOBE NEWSWIRE) -- In its first-ever attendance at Integrated Systems Europe (ISE), VITEC, a worldwide leader in advanced video encoding and streaming solutions, will showcase EZ TV - a market-leading, broadcast-grade IPTV and digital signage platform with key installations in Europe and the U.S. Targeted to enterprises, sports stadiums and arenas, and government agencies, EZ TV combines low-latency, broadcast-quality IPTV distribution with powerful digital signage capabilities to give audiences a more engaging and interactive experience. "As Europe's largest show for AV systems integrators, ISE is the perfect forum for us to present our EZ TV IPTV platform," said Bruno Teissier, sales and marketing director, VITEC. "We're looking forward to showing ISE attendees how they can help their customers distribute broadcast-quality IPTV content and access powerful digital signage capabilities in an all-in-one, integrated solution." Designed to integrate seamlessly with a
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom